Sonic Healthcare is an Australian company that operates in the United States and several other countries around the world. The company provides a range of laboratory and diagnostic services, making it one of the largest pathology companies globally. Founded in 1987 in Sydney, Australia, Sonic Healthcare has grown through a series of mergers and acquisitions to become a leading provider of pathology and radiology services.

The company's headquarters are located in Sydney, Australia. Sonic Healthcare offers a wide range of products and services, including pathology testing, imaging services, clinical services, and medical centers. The company's pathology services cover various areas such as biochemistry, hematology, microbiology, and genetics.

The imaging services include X-rays, ultrasounds, and magnetic resonance imaging (MRI) scans. Sonic Healthcare operates medical centers in various locations, providing primary healthcare services to communities. On a global scale, Sonic Healthcare has a significant presence in several countries.

The company operates in the United States, Europe, and the Asia-Pacific region. Notable subsidiaries and joint ventures include Clinical Pathology Laboratories (CPL) in the United States, Labco in Europe, and Australian Clinical Labs in Australia. In terms of market position, Sonic Healthcare is regarded as one of the largest pathology companies globally.

The company has a strong presence in the United States, where it operates through CPL. Sonic Healthcare's global sales demonstrate its prominence and success in the industry. Sonic Healthcare has achieved several milestones and notable events throughout its history.

In 2015, the company acquired Medhold, a provider of laboratory services in South Africa, expanding its presence in the African market. Over the years, Sonic Healthcare has continuously focused on strategic acquisitions and partnerships to strengthen its position in the industry and expand its service offerings. As of the latest information available, Sonic Healthcare continues to operate as a leading pathology and diagnostic services company globally.

The company remains committed to delivering high-quality services and expanding its presence in both existing and new markets